73 results
Page 3 of 4
20-F/A
EX-4.39
725dev
23 Mar 15
Annual report (foreign) (amended)
12:00am
424B2
jshwinz5 pxri4j
13 Jun 14
Prospectus for primary offering
12:00am
F-3
3d7ne0n3q4061
30 May 14
Shelf registration (foreign)
12:00am
424B3
3f73i0
8 Aug 13
Prospectus supplement
12:00am
6-K
EX-99
xgyqhsla u09jy
20 Mar 13
BioLineRx Announces Results from Interim Analysis of
12:00am
424B3
obeqz
15 Oct 12
Prospectus supplement
12:00am
F-1
5snvjnlor x6zwqe
2 Oct 12
Registration statement (foreign)
12:00am
424B3
nrggii36so2a
28 Mar 12
Prospectus supplement
12:00am
20-F
r8xb44sy065
22 Mar 12
Annual report (foreign)
12:00am
20FR12B/A
amkp7f8xzc u9
15 Jul 11
Initial registration of securities (foreign private issuers) (amended)
12:00am
20FR12B
EX-4.1
roc23g1
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.21
0u1gwofdn8nwjpkfy
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.20
8l4 5xrtzm
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.3
97f77m tvpmx2j2fs3ty
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
s5lo2no zhvvlot6w1v
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.17
w285gjzbzhn
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am